Brilla Health Cold-Flu Recovery

Manufacturer
Hadaf Llc | Santonika Uab
Effective date
2020-07-31
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 23:19:39

Label at a glance#

ProductBrilla Health Cold-Flu Recovery
Active ingredientLAPINE INTERFERON GAMMA IMMUNE GLOBULIN, LAPINE HISTAMINE IMMUNE GLOBULIN, LAPINE CD4 IMMUNE GLOBULIN
Label structure14 sections

Indications and uses

• Shorten the duration of flu and cold symptoms • Reduce severity of flu and cold symptoms, including nasal congestion, cough and sore/itchy throat

Dosage and administration

• For adults and children 1 year and older. • Hold tablet in mouth until completely dissolved, without food. If necessary, tablet can be taken dissolved in 1 tablespoon of drinking water. • Day 1: 8 tablets total for the first day 1 tablet every 30 minutes for the first 2 hours (a total of 5 tablets over 2 hours), 1 tablet taken 3 more times at equal intervals (a total of 3 tablets over the remainder of the day). ...

Storage and handling

• Store in original package below 25°C or 77°F. • Do not use if blister pack is torn or broken.

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Lapine interferon gamma immune globulin 12C, 30C, 50C Purpose: enchance magnitude of immune response

Lapine histamine immune globulin 12C, 30C, 50C Purpose: reduce histamine and inflammation response

Lapine CD4 immune globulin 12C, 30C, 50C Purpose: Enhance functional activity of immune system

Purpose

OTC - PURPOSE SECTION

Homeopathic,

Enhance magnitude of immune response

Reduce histamine and inflammation response

Enhance functional activity of immune system

Uses

INDICATIONS & USAGE SECTION

• Shorten the duration of flu and cold symptoms
• Reduce severity of flu and cold symptoms, including nasal congestion, cough and sore/itchy throat

Warnings

WARNINGS SECTION

Ask a doctor or pharmacist before use if you are lactose-intolerant.


Stop use and ask a doctor if symptoms persist or worsen.


If pregnant or breast-feeding, ask a health professional before use.


Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.


A llergic (hypersensitivity) reactions may occur in very rare cases.


Do not use if known sensitivity to Brillia Health Cold-Flu Recovery or any of its ingredients exists.

Ask a doctor

OTC - ASK DOCTOR SECTION

Ask a doctor or pharmacist before use if you are lactose-intolerant.

OTC - STOP USE SECTION

Stop use and ask a doctor if symptoms persist or worsen.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Allergic Reaction

ADVERSE REACTIONS SECTION

Allergic (hypersensitivity) reactions may occur in very rare cases.

OTC - DO NOT USE SECTION

Do not use if known sensitivity to Brillia Health Cold-Flu Recovery or any of its ingredients exists.

Directions

DOSAGE & ADMINISTRATION SECTION


• For adults and children 1 year and older.
• Hold tablet in mouth until completely dissolved, without food. If necessary, tablet can be taken dissolved in 1 tablespoon of drinking water.
• Day 1: 8 tablets total for the first day
1 tablet every 30 minutes for the first 2 hours
(a total of 5 tablets over 2 hours),
1 tablet taken 3 more times at equal intervals
(a total of 3 tablets over the remainder of the day).
• Days 2 to 5: 1 tablet 3 times a day
(at equal intervals).

Other Information

STORAGE AND HANDLING SECTION

• Store in original package below 25°C or 77°F.
• Do not use if blister pack is torn or broken.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Lactose monohydrate, Magnesium stearate, Microcrystalline cellulose.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

40 Tablets NDC: 72123-004-01

LABEL 1LABEL 1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72123-00472123-004-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
d5e1cd0d-294c-2506-e053-2995a90aca07abc3e33f-0f82-a7ed-e053-2995a90a28622022-01-18Warnings, Adverse reactionsExact identifier
spl set id: abc3e33f-0f82-a7ed-e053-2995a90a2862

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.